Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Biter AB"'
Autor:
Son J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang Y; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mirallas O; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alvarez Ballesteros P; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nardo M; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Clark N; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hillman RT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Campbell E; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Holla V; Khalifa Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Johnson AM; Khalifa Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Biter AB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cobb LP; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Euscher ED; Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lawson BC; Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yang RK; Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15; Vol. 30 (14), pp. 2986-2995.
Autor:
Son J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin HY; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fu S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Biter AB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dumbrava EE; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Karp DD; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pant S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Piha-Paul SA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rodon J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yap TA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Frumovitz MM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ramirez PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2023 Jan 06; Vol. 6 (1), pp. 10-18. Date of Electronic Publication: 2023 Jan 06 (Print Publication: 2023).
Autor:
Son J; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hsieh RC; Departments of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Radiation Oncology, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan., Lin HY; Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Krause KJ; Departments of Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Yuan Y; Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Biter AB; Departments of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Welsh J; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Curran MA; Departments of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hong DS; Departments of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Nov 11; Vol. 13, pp. 1027235. Date of Electronic Publication: 2022 Nov 11 (Print Publication: 2022).
Autor:
Akhave NS; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Biter AB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2022 Nov 03; Vol. 21 (11), pp. 1645-1651.
Autor:
Thein KZ; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Division of Hematology and Medical Oncology, Oregon Health and Science University/Knight Cancer Institute, Portland, OR., Biter AB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Banks KC; Guardant Health, Inc., Redwood City, CA., Duda AW; Guardant Health, Inc., Redwood City, CA., Saam J; Guardant Health, Inc., Redwood City, CA., Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Janku F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Skoulidis F; Department of Thoracic-Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Heymach JV; Department of Thoracic-Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Jul; Vol. 6, pp. e2100547.
Autor:
Son J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., George GC; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nardo M; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Krause KJ; Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Biter AB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: dshong@mdanderson.org.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2022 Jun; Vol. 165 (3), pp. 664-670. Date of Electronic Publication: 2022 Apr 07.
Autor:
Greenbaum U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dumbrava EI; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Biter AB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. dshong@mdanderson.org.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2021 Nov; Vol. 9 (11), pp. 1252-1261.
Autor:
Akhave NS; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Biter AB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. dshong@mdanderson.org.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 Jun; Vol. 11 (6), pp. 1345-1352. Date of Electronic Publication: 2021 Apr 05.
Autor:
Thein KZ; Division of Hematology and Medical Oncology, Oregon Health and Science University/Knight Cancer Institute, Portland, Oregon 97239, USA; email: theink@ohsu.edu., Biter AB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; email: abbiter@mdanderson.org, dshong@mdanderson.org., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; email: abbiter@mdanderson.org, dshong@mdanderson.org.
Publikováno v:
Annual review of medicine [Annu Rev Med] 2021 Jan 27; Vol. 72, pp. 349-364. Date of Electronic Publication: 2020 Nov 02.
Autor:
Liu Z; National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, 77030, USA. Electronic address: Zhuyun.Liu@bcm.edu., Kundu R; National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, 77030, USA., Damena S; Université Claude Bernard Lyon 1, Lyon, France., Biter AB; National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, 77030, USA., Nyon MP; National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, 77030, USA., Chen WH; National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, 77030, USA., Zhan B; National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, 77030, USA., Strych U; National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, 77030, USA., Hotez PJ; National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; National School of Tropical Medicine, Department of Molecular Virology & Microbiology, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, 77030, USA; Department of Biology, College of Arts and Sciences, Baylor University, Waco, TX, USA; James A. Baker III Institute for Public Policy, Rice University, Houston, TX, USA., Bottazzi ME; National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; National School of Tropical Medicine, Department of Molecular Virology & Microbiology, Baylor College of Medicine, One Baylor Plaza, BCM113, Houston, TX, 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, 77030, USA; Department of Biology, College of Arts and Sciences, Baylor University, Waco, TX, USA. Electronic address: bottazzi@bcm.edu.
Publikováno v:
Protein expression and purification [Protein Expr Purif] 2021 Jan; Vol. 177, pp. 105750. Date of Electronic Publication: 2020 Sep 10.